Stay updated with breaking news from William Chou. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PHILADELPHIA, April 22, 2024 -- Passage Bio, Inc. , a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that...
Takahiro Mori of Nippon Steel Corp. traveled to Pittsburgh for a $14 billion steel merger with US Steel. Despite promises of investment and job security, talks with union leader David McCall failed. Political tensions, including opposition from Presidents Biden and Trump, now complicate the deal, highlighting the intersection of business and politics.
(Bloomberg) -- Takahiro Mori traveled more than 12 hours from Tokyo to Pittsburgh to secure what he hoped would be one of the biggest-ever steel mergers. On the other side of the table from the Nippon Steel Corp. executive sat the one man who now appeared to have the fate of the $14 billion deal in his hands: David McCall, head of the United Steelworkers union.Most Read from BloombergIran’s Better, Stealthier Drones Are Remaking Global WarfareTrumpism Is Emptying ChurchesUkraine Says It’s Behind
PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that
U.S. Steel gives American protectionists just what they wanted … good and hard.